„First Line“
Suchergebnisse
3.416 Treffer
-
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group
-
Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
-
Meromorphic solutions on the first order non-linear difference equations
-
The first-line management of psychogenic non-epileptic seizures (PNES) in adults in the emergency: a practical approach
-
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
-
Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
-
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes
-
Efficacy of levetiracetam as first-line therapy for neonatal clinical seizures and neurodevelopmental outcome at 12 months of age
-
Failure of Current Antibiotic First-Line Regimens and Mortality in Hospitalized Patients with Spontaneous Bacterial Peritonitis
-
Role of MRI as first-line modality in the detection of previously undiagnosed otosclerosis: a single tertiary institute experience
-
Venetoclax plus obinutuzumab cost saving as first-line CLL treatment in the US
-
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
-
Intestinal epithelial barrier and mucosal immunity – A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense
-
Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy
-
Over-The-Scope Clip system as a first-line therapy for high-risk bleeding peptic ulcers: a retrospective study
-
Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review
-
NSCLC mit EGFR-Treibermutationen – Neue First-line-Option: Erlotinib plus Ramucirumab
-
Bayesian Estimation and Optimal Censoring of Inverted Generalized Linear Exponential Distribution Using Progressive First Failure Censoring
-
First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis
-
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial